Cargando…

Positive effects of Lianhuaqingwen granules in COVID-19 patients: A retrospective study of 248 cases

ETHNOPHARMACOLOGICAL RELEVANCE: Lianhuaqingwen (LHQW) is a Chinese medicine, developed from appropriate addition and reduction of combined traditional Chinese medicine (TCM) Yinqiao San and Maxing Shigan decoction. LHQW has been used in routine influenza treatment for decades and plays a role in a b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Pan, Li, Jing, Tu, Shenghao, Wu, Yanran, Peng, Yongtiao, Chen, Gang, Chen, Chao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139441/ https://www.ncbi.nlm.nih.gov/pubmed/34029640 http://dx.doi.org/10.1016/j.jep.2021.114220

Ejemplares similares

Arbidol combined with the Chinese medicine Lianhuaqingwen capsule versus arbidol alone in the treatment of COVID-19
por: Liu, Lei, et al.
Publicado: (2021)

Efficacy of Early Combination Therapy With Lianhuaqingwen and Arbidol in Moderate and Severe COVID-19 Patients: A Retrospective Cohort Study
por: Fang, Jie, et al.
Publicado: (2020)

Effect of Lianhuaqingwen Capsules on Airway Inflammation in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
por: Dong, Liang, et al.
Publicado: (2014)

A network pharmacology based approach for predicting active ingredients and potential mechanism of Lianhuaqingwen capsule in treating COVID-19
por: Zhang, Xiaobo, et al.
Publicado: (2021)

Efficacy and safety of herbal medicine (Lianhuaqingwen) for treating COVID-19: A systematic review and meta-analysis
por: Liu, Ming, et al.
Publicado: (2021)

Insights into forsythia honeysuckle (Lianhuaqingwen) capsules: A Chinese herbal medicine repurposed for COVID-19 pandemic
por: Liang, Chengyuan, et al.
Publicado: (2021)

A new perspective to improve the treatment of Lianhuaqingwen on COVID-19 and prevent the environmental health risk of medication
por: Gu, Wenwen, et al.
Publicado: (2022)

A retrospective study of Pupingqinghua prescription versus Lianhuaqingwen in Chinese participants infected with SARS-CoV-2 Omicron variants
por: Dong, Yidan, et al.
Publicado: (2022)

The clinical efficacy and safety research of Lianhuaqingwen (LHQW) in treatment of COVID-19: A systematic review and meta-analysis
por: Fang, Ling, et al.
Publicado: (2022)

The efficacy of combined therapy of qingfeiPaidu capsule and lianhuaqingwen capsule nursing interventions for hospitalized patients with COVID-19: A retrospective study of medical records
por: Li, Yan, et al.
Publicado: (2022)

Identifying potential anti-COVID-19 pharmacological components of traditional Chinese medicine Lianhuaqingwen capsule based on human exposure and ACE2 biochromatography screening
por: Chen, Xiaofei, et al.
Publicado: (2021)

Acquired hemophilia A in a woman with systemic lupus erythematosus: A case report and review of literature
por: Shen, Pan, et al.
Publicado: (2020)

Cd248a and Cd248b in zebrafish participate in innate immune responses
por: Li, Xianpeng, et al.
Publicado: (2022)

New tale on LianHuaQingWen: IL6R/IL6/IL6ST complex is a potential target for COVID-19 treatment
por: Tianyu, Zhao, et al.
Publicado: (2021)

Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2)
por: Runfeng, Li, et al.
Publicado: (2020)

The Chinese prescription lianhuaqingwen capsule exerts anti-influenza activity through the inhibition of viral propagation and impacts immune function
por: Ding, Yuewen, et al.
Publicado: (2017)

Interference in melanoma CD248 function reduces vascular mimicry and metastasis
por: Kuo, Cheng-Hsiang, et al.
Publicado: (2022)

Health Tract, No. 248: Weights and Measures
Publicado: (1866)

Efficacy and safety of Lianhuaqingwen for mild or moderate coronavirus disease 2019: A meta-analysis of randomized controlled trials
por: Fan, Zheng, et al.
Publicado: (2021)

Efficacy and Safety of Lianhuaqingwen Capsules for the Prevention of Coronavirus Disease 2019: A Prospective Open-Label Controlled Trial
por: Gong, Xiaowei, et al.
Publicado: (2021)

Testosterone and socioeconomic position: Mendelian randomization in 306,248 men and women in UK Biobank
por: Harrison, Sean, et al.
Publicado: (2021)

Pharmacokinetics-based identification of pseudoaldosterogenic compounds originating from Glycyrrhiza uralensis roots (Gancao) after dosing LianhuaQingwen capsule
por: Lan, Xiao-fang, et al.
Publicado: (2021)

P248 Fungal meningitis in an immunocompetent individual
por: Ningthoujam, Priyolakshmi, et al.
Publicado: (2022)

A novel PMP22 insertion mutation causing Charcot–Marie–Tooth disease type 3: A case report
por: Han, Liang, et al.
Publicado: (2021)

Targeting fibroblast CD248 attenuates CCL17-expressing macrophages and tissue fibrosis
por: Pai, Chen-Hsueh, et al.
Publicado: (2020)

The Diagnostic and Immunotherapeutic Value of CD248 in Renal Cell Carcinoma
por: Zhang, Keying, et al.
Publicado: (2021)

Effects of Lianhuaqingwen Capsules in adults with mild-to-moderate coronavirus disease 2019: an international, multicenter, double-blind, randomized controlled trial
por: Zheng, Jin-ping, et al.
Publicado: (2023)

Different clinical presentations of two renal transplant recipients with coronavirus disease 2019: a case report
por: Li, Jing, et al.
Publicado: (2020)

Correction to Lancet Oncol 2016; 17: 248, 252
Publicado: (2016)

Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: A multicenter, prospective, randomized controlled trial
por: Hu, Ke, et al.
Publicado: (2021)

Elastic scattering of positive kaons on polarized protons at 1.22 and 2.48 GeV/c
por: Andersson, S, et al.
Publicado: (1969)

TH-248. Electrophysiologic changes in patients with new-onset neuromuscular disorder after COVID-19
por: İlhan Algın, Demet, et al.
Publicado: (2022)

CD248 as a novel therapeutic target in pulmonary arterial hypertension
por: Xu, Tao, et al.
Publicado: (2020)

Balloon Eustachian tuboplasty for obstructive Eustachian tube dysfunction: retrospective multicentre cohort study of 248 patients
por: Sandoval, Marta, et al.
Publicado: (2023)

Corrigendum to: Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2) [Pharmacol. Res. 156 (2020) 104761]
por: Runfeng, Li, et al.
Publicado: (2021)

Exotic decay modes of $^{248}Cm$ and $^{252}Cf$ nuclei
por: Pyatkov, Yu V
Publicado: (1998)

S248. RELATION BETWEEN CHILDHOOD TRAUMA AND PSYCHOTIC SYMPTOMS IN SCHIZOPHRENIA
por: Larnaout, Amine, et al.
Publicado: (2018)

CD248: A therapeutic target in cancer and fibrotic diseases
por: Teicher, Beverly A.
Publicado: (2019)

Esophageal feeding tube placement and the associated complications in 248 cats
por: Breheny, Craig R., et al.
Publicado: (2019)

Preoperative lymphocyte-monocyte ratio is not an independent prognostic factor in M0 (stage I–III) esophageal squamous cell carcinomas
por: Chen, Chao, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vfqg23se3vjbjjedecprd63q2t